RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Absolutely. I only mentioned the math because it is incontrovertibly bad. R&R can argue that no events should be assumed based on past history, blah blah...and they could state that my disagreement is based on a positive bias towards the company. Similarly, they could claim that the value of the IP is in doubt.

But they can't have all the shares diluted (and then some) including the 30 odd million that are based on options currently underwater, and which--if the share price remains where R&R says it will be--will never be above water. And if all the shares are out, it means the share price would have to approach 3.00 (I don't remember all the points of conversion, but some of them are in the 2.60-2.70 range). R&R is trying to have it both ways, and mathematically, that's impossible. Unbelievably sloppy.

NeuroInvestment